{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:25:31Z","timestamp":1793179531628,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s40265-024-02048-x","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T07:02:07Z","timestamp":1718866927000},"page":"779-809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews"],"prefix":"10.1007","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0921-342X","authenticated-orcid":false,"given":"Giancarlo","family":"De la Torre Canales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9961-121X","authenticated-orcid":false,"given":"Mariana Barbosa","family":"C\u00e2mara-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4152-5439","authenticated-orcid":false,"given":"Malin","family":"Ernberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3649-9662","authenticated-orcid":false,"given":"Essam Ahmed","family":"Al-Moraissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3323-8299","authenticated-orcid":false,"given":"Anastasios","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7180-6448","authenticated-orcid":false,"given":"Rodrigo Lorenzi","family":"Poluha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-6855","authenticated-orcid":false,"given":"Maria","family":"Christidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2352-8070","authenticated-orcid":false,"given":"Hajer","family":"Jasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2920-6654","authenticated-orcid":false,"given":"Anna","family":"L\u00f6vgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8199-7863","authenticated-orcid":false,"given":"Nikolaos","family":"Christidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"issue":"8","key":"2048_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrmicro3295","volume":"12","author":"O Rossetto","year":"2014","unstructured":"Rossetto O, Pirazzini M, Montecucco C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol. 2014;12(8):535\u201349. https:\/\/doi.org\/10.1038\/nrmicro3295. (Epub 2014\/07\/01. PubMed PMID: 24975322).","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"2048_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1124\/pr.116.012658","volume":"69","author":"M Pirazzini","year":"2017","unstructured":"Pirazzini M, Rossetto O, Eleopra R, Montecucco C. Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev. 2017;69(2):200\u201335. https:\/\/doi.org\/10.1124\/pr.116.012658. (Epub 2017\/03\/31. PubMed PMID: 28356439; PubMed Central PMCID: PMCPMC5394922).","journal-title":"Pharmacol Rev"},{"key":"2048_CR3","doi-asserted-by":"publisher","first-page":"14130","DOI":"10.1038\/ncomms14130","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang S, Masuyer G, Zhang J, Shen Y, Lundin D, Henriksson L, et al. Identification and characterization of a novel botulinum neurotoxin. Nat Commun. 2017;8:14130. https:\/\/doi.org\/10.1038\/ncomms14130. (Epub 2017\/08\/05. PubMed PMID: 28770820; PubMed Central PMCID: PMCPMC5543303 62\/360,239) for medical use of BoNT\/X, with P.S., S.Z. and M.D. as inventors).","journal-title":"Nat Commun"},{"key":"2048_CR4","doi-asserted-by":"publisher","unstructured":"Alimohammadi M, Punga AR. Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations. Toxins (Basel). 2017;9(11). Epub 2017\/10\/31. https:\/\/doi.org\/10.3390\/toxins9110352. PubMed PMID: 29084148; PubMed Central PMCID: PMCPMC5705967.","DOI":"10.3390\/toxins9110352"},{"issue":"7","key":"2048_CR5","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.3390\/toxins7072435","volume":"7","author":"DW Kim","year":"2015","unstructured":"Kim DW, Lee SK, Ahnn J. Botulinum toxin as a pain killer: players and actions in antinociception. Toxins (Basel). 2015;7(7):2435\u201353. https:\/\/doi.org\/10.3390\/toxins7072435. (Epub 2015\/07\/03. PubMed PMID: 26134255; PubMed Central PMCID: PMCPMC4516922).","journal-title":"Toxins (Basel)."},{"key":"2048_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11080459","author":"I Matak","year":"2019","unstructured":"Matak I, Bolcskei K, Bach-Rojecky L, Helyes Z. Mechanisms of botulinum toxin type A action on pain. Toxins (Basel). 2019. https:\/\/doi.org\/10.3390\/toxins11080459. (Epub 2019\/08\/08. PubMed PMID: 31387301; PubMed Central PMCID: PMCPMC6723487).","journal-title":"Toxins (Basel)."},{"issue":"1\u20132","key":"2048_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","volume":"107","author":"M Cui","year":"2004","unstructured":"Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004;107(1\u20132):125\u201333. https:\/\/doi.org\/10.1016\/j.pain.2003.10.008. (Epub 2004\/01\/13 PubMed PMID: 14715398).","journal-title":"Pain"},{"issue":"6 Suppl","key":"2048_CR8","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1097\/00002508-200211001-00003","volume":"18","author":"JC Arezzo","year":"2002","unstructured":"Arezzo JC. Possible mechanisms for the effects of botulinum toxin on pain. Clin J Pain. 2002;18(6 Suppl):S125\u201332. https:\/\/doi.org\/10.1097\/00002508-200211001-00003. (Epub 2003\/02\/07 PubMed PMID: 12569959).","journal-title":"Clin J Pain"},{"issue":"2","key":"2048_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.pbb.2009.08.012","volume":"94","author":"L Bach-Rojecky","year":"2009","unstructured":"Bach-Rojecky L, Lackovic Z. Central origin of the antinociceptive action of botulinum toxin type A. Pharmacol Biochem Behav. 2009;94(2):234\u20138. https:\/\/doi.org\/10.1016\/j.pbb.2009.08.012. (Epub 2009\/09\/08 PubMed PMID: 19732788).","journal-title":"Pharmacol Biochem Behav"},{"key":"2048_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","volume":"186","author":"I Matak","year":"2011","unstructured":"Matak I, Bach-Rojecky L, Filipovic B, Lackovic Z. Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience. 2011;186:201\u20137. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.04.026. (Epub 2011\/05\/05 PubMed PMID: 21539899).","journal-title":"Neuroscience"},{"issue":"6","key":"2048_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00702-013-1150-6","volume":"121","author":"V Drinovac","year":"2014","unstructured":"Drinovac V, Bach-Rojecky L, Lackovic Z. Association of antinociceptive action of botulinum toxin type A with GABA-A receptor. J Neural Transm (Vienna). 2014;121(6):665\u20139. https:\/\/doi.org\/10.1007\/s00702-013-1150-6. (Epub 2014\/01\/15 PubMed PMID: 24420081).","journal-title":"J Neural Transm (Vienna)"},{"key":"2048_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.toxicon.2020.08.027","volume":"187","author":"VR Manuel Munoz-Lora","year":"2020","unstructured":"Manuel Munoz-Lora VR, Abdalla HB, Del Bel Cury AA, Clemente-Napimoga JT. Modulatory effect of botulinum toxin type A on the microglial P2X7\/CatS\/FKN activated-pathway in antigen-induced arthritis of the temporomandibular joint of rats. Toxicon. 2020;187:116\u201321. https:\/\/doi.org\/10.1016\/j.toxicon.2020.08.027. (Epub 2020\/09\/04 PubMed PMID: 32882256).","journal-title":"Toxicon"},{"issue":"10","key":"2048_CR13","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1212\/wnl.56.10.1290","volume":"56","author":"L Foster","year":"2001","unstructured":"Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology. 2001;56(10):1290\u20133. https:\/\/doi.org\/10.1212\/wnl.56.10.1290. (Epub 2001\/05\/29 PubMed PMID: 11376175).","journal-title":"Neurology"},{"issue":"7","key":"2048_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/0333102410364677","volume":"30","author":"HC Diener","year":"2010","unstructured":"Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30(7):804\u201314. https:\/\/doi.org\/10.1177\/0333102410364677. (Epub 2010\/07\/22 PubMed PMID: 20647171).","journal-title":"Cephalalgia"},{"issue":"6","key":"2048_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S1474-4422(16)00017-X","volume":"15","author":"N Attal","year":"2016","unstructured":"Attal N, de Andrade DC, Adam F, Ranoux D, Teixeira MJ, Galhardoni R, et al. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2016;15(6):555\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(16)00017-X. (Epub 2016\/03\/08 PubMed PMID: 26947719).","journal-title":"Lancet Neurol"},{"key":"2048_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12020110","author":"CL Chen","year":"2020","unstructured":"Chen CL, Meng E. Can botulinum toxin A play a role in treatment of chronic pelvic pain syndrome in female patients?-Clinical and animal evidence. Toxins (Basel). 2020. https:\/\/doi.org\/10.3390\/toxins12020110. (Epub 2020\/02\/14. PubMed PMID: 32050685; PubMed Central PMCID: PMCPMC7076794).","journal-title":"Toxins (Basel)."},{"key":"2048_CR17","doi-asserted-by":"publisher","first-page":"1306475","DOI":"10.3389\/fpain.2023.1306475","volume":"4","author":"G Barjandi","year":"2023","unstructured":"Barjandi G, Svedenlof J, Jasim H, Collin M, Hedenberg-Magnusson B, Christidis N, et al. Clinical aspects of mastication myalgia-an overview. Front Pain Res (Lausanne). 2023;4:1306475. https:\/\/doi.org\/10.3389\/fpain.2023.1306475. (PubMed PMID: 38264542; PubMed Central PMCID: PMCPMC10803665).","journal-title":"Front Pain Res (Lausanne)."},{"issue":"7","key":"2048_CR18","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/joor.12960","volume":"47","author":"EA Al-Moraissi","year":"2020","unstructured":"Al-Moraissi EA, Alradom J, Aladashi O, Goddard G, Christidis N. Needling therapies in the management of myofascial pain of the masticatory muscles: a network meta-analysis of randomised clinical trials. J Oral Rehabil. 2020;47(7):910\u201322. https:\/\/doi.org\/10.1111\/joor.12960. (Epub 2020\/03\/12 PubMed PMID: 32159870).","journal-title":"J Oral Rehabil"},{"key":"2048_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10006-021-01009-y","volume":"21","author":"EA Al-Moraissi","year":"2021","unstructured":"Al-Moraissi EA, Conti PCR, Alyahya A, Alkebsi K, Elsharkawy A, Christidis N. The hierarchy of different treatments for myogenous temporomandibular disorders: a systematic review and network meta-analysis of randomized clinical trials. Oral Maxillofac Surg. 2021;21:21. https:\/\/doi.org\/10.1007\/s10006-021-01009-y. (PubMed PMID: 34674093).","journal-title":"Oral Maxillofac Surg"},{"issue":"1","key":"2048_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.prosdent.2020.08.015","volume":"126","author":"AS Alkhutari","year":"2021","unstructured":"Alkhutari AS, Alyahya A, Conti PCR, Christidis N, Al-Moraissi EA. Is the therapeutic effect of occlusal stabilization appliances more than just placebo effect in the management of painful temporomandibular disorders? A network meta-analysis of randomized clinical trials. J Prosthet Dent. 2021;126(1):24\u201332. https:\/\/doi.org\/10.1016\/j.prosdent.2020.08.015. (PubMedPMID:WOS:000670295900006).","journal-title":"J Prosthet Dent"},{"issue":"1","key":"2048_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40265-023-01971-9","volume":"84","author":"N Christidis","year":"2024","unstructured":"Christidis N, Al-Moraissi EA, Barjandi G, Svedenlof J, Jasim H, Christidis M, et al. Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis. Drugs. 2024;84(1):59\u201381. https:\/\/doi.org\/10.1007\/s40265-023-01971-9. (Epub 2023\/12\/16 PubMed PMID: 38103150; PubMed Central PMCID: PMCPMC10789663 Svedenlof, Hajer Jasim, Maria Christidis, and Malin Collin declare that they have no conflicts of interest that might be relevant to the contents of this manuscript).","journal-title":"Drugs"},{"issue":"2\u20133","key":"2048_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s0304-3959(97)00194-2","volume":"74","author":"R Ohrbach","year":"1998","unstructured":"Ohrbach R, Dworkin SF. Five-year outcomes in TMD: relationship of changes in pain to changes in physical and psychological variables. Pain. 1998;74(2\u20133):315\u201326. https:\/\/doi.org\/10.1016\/s0304-3959(97)00194-2. (Epub 1998\/03\/31 PubMed PMID: 9520246).","journal-title":"Pain"},{"issue":"1","key":"2048_CR23","first-page":"39","volume":"101","author":"JJ von Lindern","year":"2001","unstructured":"von Lindern JJ. Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction. Acta Neurol Belg. 2001;101(1):39\u201341 (Epub 2001\/05\/31 PubMed PMID: 11379274).","journal-title":"Acta Neurol Belg"},{"issue":"3","key":"2048_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0304-3959(02)00240-3","volume":"99","author":"DR Nixdorf","year":"2002","unstructured":"Nixdorf DR, Heo G, Major PW. Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain. Pain. 2002;99(3):465\u201373. https:\/\/doi.org\/10.1016\/S0304-3959(02)00240-3. (Epub 2002\/10\/31 PubMed PMID: 12406522).","journal-title":"Pain"},{"issue":"8","key":"2048_CR25","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.joms.2008.03.008","volume":"66","author":"C Kurtoglu","year":"2008","unstructured":"Kurtoglu C, Gur OH, Kurkcu M, Sertdemir Y, Guler-Uysal F, Uysal H. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. J Oral Maxillofac Surg. 2008;66(8):1644\u201351. https:\/\/doi.org\/10.1016\/j.joms.2008.03.008. (Epub 2008\/07\/19 PubMed PMID: 18634953).","journal-title":"J Oral Maxillofac Surg"},{"issue":"9","key":"2048_CR26","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.pain.2011.03.036","volume":"152","author":"M Ernberg","year":"2011","unstructured":"Ernberg M, Hedenberg-Magnusson B, List T, Svensson P. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain. 2011;152(9):1988\u201396. https:\/\/doi.org\/10.1016\/j.pain.2011.03.036. (Epub 2011\/04\/26 PubMed PMID: 21514731).","journal-title":"Pain"},{"issue":"4","key":"2048_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/0003489417693013","volume":"126","author":"AA Patel","year":"2017","unstructured":"Patel AA, Lerner MZ, Blitzer A. IncobotulinumtoxinA injection for temporomandibular joint disorder. Ann Otol Rhinol Laryngol. 2017;126(4):328\u201333. https:\/\/doi.org\/10.1177\/0003489417693013. (Epub 2017\/03\/16. PubMed PMID: 28290229).","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2048_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12060395","author":"G De la Torre Canales","year":"2020","unstructured":"De la Torre Canales G, Alvarez-Pinzon N, Mu\u00f1oz-Lora VRM, Vieira Peroni L, Farias Gomes A, S\u00e1nchez-Ayala A, et al. Efficacy and safety of botulinum toxin type a on persistent myofascial pain: a randomized clinical trial. Toxins (Basel). 2020. https:\/\/doi.org\/10.3390\/toxins12060395. (Epub 2020\/06\/19. PubMed PMID: 32549196; PubMed Central PMCID: PMCPMC7354430).","journal-title":"Toxins (Basel)."},{"issue":"1","key":"2048_CR29","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1038\/s41598-024-54906-z","volume":"14","author":"G De la Torre Canales","year":"2024","unstructured":"De la Torre Canales G, Poluha RL, Bonjardim LR, Ernberg M, Conti PCR. Botulinum toxin-A effects on pain, somatosensory and psychosocial features of patients with refractory masticatory myofascial pain: a randomized double-blind clinical trial. Sci Rep. 2024;14(1):4201. https:\/\/doi.org\/10.1038\/s41598-024-54906-z. (Epub 2024\/02\/21. PubMed PMID: 38378855; PubMed Central PMCID: PMCPMC10879180).","journal-title":"Sci Rep"},{"issue":"3","key":"2048_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/joor.12747","volume":"46","author":"J Balanta-Melo","year":"2019","unstructured":"Balanta-Melo J, Torres-Quintana MA, Bemmann M, Vega C, Gonzalez C, Kupczik K, et al. Masseter muscle atrophy impairs bone quality of the mandibular condyle but not the alveolar process early after induction. J Oral Rehabil. 2019;46(3):233\u201341. https:\/\/doi.org\/10.1111\/joor.12747. (Epub 2018\/11\/24. PubMed PMID: 30468522).","journal-title":"J Oral Rehabil"},{"issue":"1","key":"2048_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jbiomech.2010.08.020","volume":"44","author":"R Fortuna","year":"2011","unstructured":"Fortuna R, Vaz MA, Youssef AR, Longino D, Herzog W. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox). J Biomech. 2011;44(1):39\u201344.","journal-title":"J Biomech"},{"issue":"3","key":"2048_CR32","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00784-012-0750-0","volume":"17","author":"T Gedrange","year":"2013","unstructured":"Gedrange T, Gredes T, Spassov A, Mai R, Kuhn DU, Dominiak M, et al. Histological changes and changes in the myosin mRNA content of the porcine masticatory muscles after masseter treatment with botulinum toxin A. Clin Oral Investig. 2013;17(3):887\u201396. https:\/\/doi.org\/10.1007\/s00784-012-0750-0. (Epub 2012\/06\/16. PubMed PMID: 22699659).","journal-title":"Clin Oral Investig"},{"issue":"6","key":"2048_CR33","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1097\/01.prs.0000282309.94147.22","volume":"120","author":"KY Ahn","year":"2007","unstructured":"Ahn KY, Kim ST. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy. Plast Reconstr Surg. 2007;120(6):1662\u20136. https:\/\/doi.org\/10.1097\/01.prs.0000282309.94147.22. (Epub 2007\/11\/28. PubMed PMID: 18040203).","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"2048_CR34","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/j.1524-4725.2009.01319.x","volume":"35","author":"KS Kim","year":"2009","unstructured":"Kim KS, Byun YS, Kim YJ, Kim ST. Muscle weakness after repeated injection of botulinum toxin type A evaluated according to bite force measurement of human masseter muscle. Dermatol Surg. 2009;35(12):1902\u20137.","journal-title":"Dermatol Surg"},{"key":"2048_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11020084","author":"J Balanta-Melo","year":"2019","unstructured":"Balanta-Melo J, Toro-Ibacache V, Kupczik K, Buvinic S. Mandibular bone loss after masticatory muscles intervention with botulinum toxin: an approach from basic research to clinical findings. Toxins (Basel). 2019. https:\/\/doi.org\/10.3390\/toxins11020084. (Epub 2019\/02\/06. PubMed PMID: 30717172; PubMed Central PMCID: PMCPMC6409568).","journal-title":"Toxins (Basel)."},{"issue":"2","key":"2048_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/joor.13590","volume":"51","author":"MS Moussa","year":"2024","unstructured":"Moussa MS, Bachour D, Komarova SV. Adverse effect of botulinum toxin-A injections on mandibular bone: a systematic review and meta-analysis. J Oral Rehabil. 2024;51(2):404\u201315. https:\/\/doi.org\/10.1111\/joor.13590. (Epub 2023\/09\/05. PubMed PMID: 37668276).","journal-title":"J Oral Rehabil"},{"issue":"3","key":"2048_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","volume":"13","author":"E Aromataris","year":"2015","unstructured":"Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132\u201340. https:\/\/doi.org\/10.1097\/XEB.0000000000000055. (Epub 2015\/09\/12. PubMed PMID: 26360830).","journal-title":"Int J Evid Based Healthc"},{"issue":"2","key":"2048_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5195\/jmla.2020.834","volume":"108","author":"JM Clark","year":"2020","unstructured":"Clark JM, Sanders S, Carter M, Honeyman D, Cleo G, Auld Y, et al. Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial. J Med Libr Assoc. 2020;108(2):195\u2013207. https:\/\/doi.org\/10.5195\/jmla.2020.834. (Epub 2020\/04\/08. PubMed PMID: 32256231; PubMed Central PMCID: PMCPMC7069833 developing the Polyglot Search Translator from the Australian Library Information Association. All other authors declare that they have no other competing interests).","journal-title":"J Med Libr Assoc"},{"issue":"3","key":"2048_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","volume":"104","author":"WM Bramer","year":"2016","unstructured":"Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016;104(3):240\u20133. https:\/\/doi.org\/10.3163\/1536-5050.104.3.014. (Epub 2016\/07\/02. PubMed PMID: 27366130; PubMed Central PMCID: PMCPMC4915647).","journal-title":"J Med Libr Assoc"},{"issue":"1","key":"2048_CR40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4. (Epub 2016\/12\/07. PubMed PMID: 27919275; PubMed Central PMCID: PMCPMC5139140).","journal-title":"Syst Rev"},{"key":"2048_CR41","unstructured":"Aromataris E, Fernandez RS, Godfrey C, Holly C, Khalil H, Tungpunkom P. Methodology for JBI umbrella reviews. Joanna Briggs Institute reviewer's manual 2014. Adelaide, Australia: Joanna Briggs Institute; 2014."},{"issue":"4","key":"2048_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/AJP.0000000000000681","volume":"35","author":"S Ahmed","year":"2019","unstructured":"Ahmed S, Subramaniam S, Sidhu K, Khattab S, Singh D, Babineau J, et al. Effect of local anesthetic versus botulinum toxin-A injections for myofascial pain disorders: a systematic review and meta-analysis. Clin J Pain. 2019;35(4):353\u201367. https:\/\/doi.org\/10.1097\/AJP.0000000000000681. (Epub 2018\/12\/28. PubMed PMID: 30589660).","journal-title":"Clin J Pain"},{"key":"2048_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030788","author":"M Arribas-Pascual","year":"2023","unstructured":"Arribas-Pascual M, Hernandez-Hernandez S, Jimenez-Arranz C, Grande-Alonso M, Angulo-Diaz-Parreno S, La Touche R, et al. Effects of physiotherapy on pain and mouth opening in temporomandibular disorders: an umbrella and mapping systematic review with meta-meta-analysis. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12030788. (Epub 2023\/02\/12. PubMed PMID: 36769437; PubMed Central PMCID: PMCPMC9917698).","journal-title":"J Clin Med"},{"issue":"3","key":"2048_CR44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/jop.12822","volume":"48","author":"KH Awan","year":"2019","unstructured":"Awan KH, Patil S, Alamir AWH, Maddur N, Arakeri G, Carrozzo M, et al. Botulinum toxin in the management of myofascial pain associated with temporomandibular dysfunction. J Oral Pathol Med. 2019;48(3):192\u2013200. https:\/\/doi.org\/10.1111\/jop.12822. (Epub 2019\/01\/04. PubMed PMID: 30604895).","journal-title":"J Oral Pathol Med"},{"issue":"9","key":"2048_CR45","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1007\/s00784-019-03026-4","volume":"23","author":"G De la Torre Canales","year":"2019","unstructured":"De la Torre Canales G, Poluha RL, Lora VM, Araujo Ferreira DM, Stuginski-Barbosa J, Bonjardim LR, et al. Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects? Clin Oral Investig. 2019;23(9):3411\u201321. https:\/\/doi.org\/10.1007\/s00784-019-03026-4.","journal-title":"Clin Oral Investig"},{"issue":"1","key":"2048_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.11607\/ofph.3023","volume":"36","author":"R Delcanho","year":"2022","unstructured":"Delcanho R, Val M, Guarda Nardini L, Manfredini D. Botulinum toxin for treating temporomandibular disorders: what is the evidence? J Oral Facial Pain Headache. 2022;36(1):6\u201320. https:\/\/doi.org\/10.11607\/ofph.3023.","journal-title":"J Oral Facial Pain Headache"},{"issue":"3","key":"2048_CR47","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00784-017-2092-4","volume":"21","author":"G De la Torre Canales","year":"2017","unstructured":"De la Torre Canales G, Camara-Souza MB, do Amaral CF, Garcia RC, Manfredini D. Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review. Clin Oral Investig. 2017;21(3):727\u201334. https:\/\/doi.org\/10.1007\/s00784-017-2092-4. (Epub 2017\/03\/04. PubMed PMID: 28255752).","journal-title":"Clin Oral Investig"},{"issue":"23","key":"2048_CR48","doi-asserted-by":"publisher","first-page":"12409","DOI":"10.3390\/app122312409","volume":"12","author":"F Di Francesco","year":"2022","unstructured":"Di Francesco F, Lanza A, Di Blasio M, Vaienti B, Cafferata EA, Cervino G, et al. Application of botulinum toxin in temporomandibular disorders: a systematic review of randomized controlled trials (RCTs). Appl Sci. 2022;12(23):12409. https:\/\/doi.org\/10.3390\/app122312409.","journal-title":"Appl Sci"},{"issue":"46","key":"2048_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017934","volume":"98","author":"J Feng","year":"2019","unstructured":"Feng J, Luo M, Ma J, Tian Y, Han X, Bai D. The treatment modalities of masticatory muscle pain a network meta-analysis. Medicine (Baltimore). 2019;98(46): e17934. https:\/\/doi.org\/10.1097\/MD.0000000000017934. (Epub 2019\/11\/15. PubMed PMID: 31725647; PubMed Central PMCID: PMCPMC6867722).","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2048_CR50","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/09638288.2023.2165731","volume":"46","author":"D Griswold","year":"2024","unstructured":"Griswold D, Learman K, Ickert E, Clewley D, Donaldson MB, Wilhelm M, et al. Comparing dry needling or local acupuncture to various wet needling injection types for musculoskeletal pain and disability. A systematic review of randomized clinical trials. Disabil Rehabil. 2024;46(3):414\u201328. https:\/\/doi.org\/10.1080\/09638288.2023.2165731. (Epub 2023\/01\/13. PubMed PMID: 36633385).","journal-title":"Disabil Rehabil"},{"issue":"12","key":"2048_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.adaj.2016.08.022","volume":"147","author":"M Khalifeh","year":"2016","unstructured":"Khalifeh M, Mehta K, Varguise N, Suarez-Durall P, Enciso R. Botulinum toxin type A for the treatment of head and neck chronic myofascial pain syndrome: a systematic review and meta-analysis. J Am Dent Assoc. 2016;147(12):959-73e1. https:\/\/doi.org\/10.1016\/j.adaj.2016.08.022. (Epub 2016\/10\/16. PubMed PMID: 27737756).","journal-title":"J Am Dent Assoc"},{"issue":"3\u20134","key":"2048_CR52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpain.2019.08.011","volume":"21","author":"D Machado","year":"2020","unstructured":"Machado D, Martimbianco ALC, Bussadori SK, Pacheco RL, Riera R, Santos EM. Botulinum toxin type A for painful temporomandibular disorders: systematic review and meta-analysis. J Pain. 2020;21(3\u20134):281\u201393. https:\/\/doi.org\/10.1016\/j.jpain.2019.08.011. (Epub 2019\/09\/13. PubMed PMID: 31513934).","journal-title":"J Pain"},{"issue":"11","key":"2048_CR53","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.ijom.2018.05.003","volume":"47","author":"E Machado","year":"2018","unstructured":"Machado E, Machado P, Wandscher VF, Marchionatti AME, Zanatta FB, Kaizer OB. A systematic review of different substance injection and dry needling for treatment of temporomandibular myofascial pain. Int J Oral Maxillofac Surg. 2018;47(11):1420\u201332. https:\/\/doi.org\/10.1016\/j.ijom.2018.05.003. (Epub 2018\/05\/29. PubMed PMID: 29801994).","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"6","key":"2048_CR54","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/joor.13326","volume":"49","author":"M Owen","year":"2022","unstructured":"Owen M, Gray B, Hack N, Perez L, Allard RJ, Hawkins JM. Impact of botulinum toxin injection into the masticatory muscles on mandibular bone: a systematic review. J Oral Rehabil. 2022;49(6):644\u201353. https:\/\/doi.org\/10.1111\/joor.13326. (Epub 2022\/03\/30. PubMed PMID: 35348239).","journal-title":"J Oral Rehabil"},{"issue":"2","key":"2048_CR55","doi-asserted-by":"publisher","first-page":"271","DOI":"10.17219\/dmp\/145759","volume":"59","author":"RM Ramos-Herrada","year":"2022","unstructured":"Ramos-Herrada RM, Arriola-Guillen LE, Atoche-Socola KJ, Bellini-Pereira SA, Castillo AA. Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: a systematic review. Dent Med Probl. 2022;59(2):271\u201380. https:\/\/doi.org\/10.17219\/dmp\/145759. (Epub 2022\/07\/02. PubMed PMID: 35775414).","journal-title":"Dent Med Probl."},{"issue":"1","key":"2048_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10787-010-0069-x","volume":"19","author":"T Zhang","year":"2011","unstructured":"Zhang T, Adatia A, Zarin W, Moitri M, Vijenthira A, Chu R, et al. The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis. Inflammopharmacology. 2011;19(1):21\u201334. https:\/\/doi.org\/10.1007\/s10787-010-0069-x. (Epub 2010\/11\/16. PubMed PMID: 21076878).","journal-title":"Inflammopharmacology"},{"issue":"4","key":"2048_CR57","first-page":"1","volume":"8","author":"FA Almutairi","year":"2020","unstructured":"Almutairi FA, Almansour MM, Almansour IM, Alwazzan RA, Alrashaid HM, Baseer MA. The role of botox in the management of TMJ disorders\u2014a systematic review. Ann Dent Spec. 2020;8(4):1\u20139.","journal-title":"Ann Dent Spec."},{"issue":"2","key":"2048_CR58","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bjoms.2021.03.005","volume":"60","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Yuan L, Ma L, Pang F, Qu X, Zhang A. Efficacy of botulinum-A for nocturnal bruxism pain and the occurrence of bruxism events: a meta-analysis and systematic review. Br J Oral Maxillofac Surg. 2022;60(2):174\u201382. https:\/\/doi.org\/10.1016\/j.bjoms.2021.03.005. (Epub 2021\/12\/28. PubMed PMID: 34955330).","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"8","key":"2048_CR59","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ijom.2015.04.003","volume":"44","author":"YW Chen","year":"2015","unstructured":"Chen YW, Chiu YW, Chen CY, Chuang SK. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials. Int J Oral Maxillofac Surg. 2015;44(8):1018\u201326. https:\/\/doi.org\/10.1016\/j.ijom.2015.04.003. (Epub 2015\/04\/30. PubMed PMID: 25920597).","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2048_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41432-022-0256-9","author":"IN Pereira","year":"2022","unstructured":"Pereira IN, Hassan H. Botulinum toxin A in dentistry and orofacial surgery: an evidence-based review - part 1: therapeutic applications. Evid Based Dent. 2022. https:\/\/doi.org\/10.1038\/s41432-022-0256-9. (Epub 2022\/05\/28. PubMed PMID: 35624296).","journal-title":"Evid Based Dent"},{"issue":"4","key":"2048_CR61","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.4317\/medoral.22923","volume":"24","author":"T Fernandez-Nunez","year":"2019","unstructured":"Fernandez-Nunez T, Amghar-Maach S, Gay-Escoda C. Efficacy of botulinum toxin in the treatment of bruxism: systematic review. Med Oral Patol Oral Cir Bucal. 2019;24(4):e416\u201324. https:\/\/doi.org\/10.4317\/medoral.22923. (Epub 2019\/06\/28. PubMed PMID: 31246937; PubMed Central PMCID: PMCPMC6667018 interest exist).","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"16","key":"2048_CR62","first-page":"428","volume":"30","author":"SN Rajamoorthy","year":"2023","unstructured":"Rajamoorthy SN. Botulinum toxin-A injections into facial muscles for the treatment of temporomandibular disorders and bruxism: a systematic review. J Popul Ther Clin Pharmacol. 2023;30(16):428\u201352.","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"5","key":"2048_CR63","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.bjoms.2020.02.007","volume":"58","author":"S Thambar","year":"2020","unstructured":"Thambar S, Kulkarni S, Armstrong S, Nikolarakos D. Botulinum toxin in the management of temporomandibular disorders: a systematic review. Br J Oral Maxillofac Surg. 2020;58(5):508\u201319. https:\/\/doi.org\/10.1016\/j.bjoms.2020.02.007. (Epub 2020\/03\/08. PubMed PMID: 32143934).","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"2","key":"2048_CR64","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00266-023-03256-8","volume":"47","author":"Y Chen","year":"2023","unstructured":"Chen Y, Tsai CH, Bae TH, Huang CY, Chen C, Kang YN, et al. Effectiveness of botulinum toxin injection on bruxism: a systematic review and meta-analysis of randomized controlled trials. Aesthetic Plast Surg. 2023;47(2):775\u201390. https:\/\/doi.org\/10.1007\/s00266-023-03256-8. (Epub 2023\/01\/25. PubMed PMID: 36694050).","journal-title":"Aesthetic Plast Surg"},{"key":"2048_CR65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1590\/S1806-00132013000100013","volume":"14","author":"M Dall'Antonia","year":"2013","unstructured":"Dall\u2019Antonia M, Netto RMdO, Sanches ML, Guimar\u00e3es AS. Jaw muscles myofascial pain and botulinum toxin. Revista Dor. 2013;14:52\u20137.","journal-title":"Revista Dor."},{"issue":"3","key":"2048_CR66","doi-asserted-by":"publisher","first-page":"152","DOI":"10.11606\/issn.2317-0190.v21i3a103862","volume":"21","author":"MM de Mello Sposito","year":"2014","unstructured":"de Mello Sposito MM, Teixeira SAF. Botulinum Toxin Type A in the treatment of myofascial pain related to masticatory muscles. Acta Fisi\u00e1trica. 2014;21(3):152\u20137.","journal-title":"Acta Fisi\u00e1trica."},{"key":"2048_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18189552","author":"Z Nowak","year":"2021","unstructured":"Nowak Z, Checinski M, Nitecka-Buchta A, Bulanda S, Ilczuk-Rypula D, Postek-Stefanska L, et al. Intramuscular injections and dry needling within masticatory muscles in management of myofascial pain. Systematic review of clinical trials. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18189552. (Epub 2021\/09\/29. PubMed PMID: 34574476; PubMed Central PMCID: PMCPMC8465617).","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"2048_CR68","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41415-019-0257-z","volume":"226","author":"J Patel","year":"2019","unstructured":"Patel J, Cardoso JA, Mehta S. A systematic review of botulinum toxin in the management of patients with temporomandibular disorders and bruxism. Br Dent J. 2019;226(9):667\u201372. https:\/\/doi.org\/10.1038\/s41415-019-0257-z. (Epub 2019\/05\/12. PubMed PMID: 31076698).","journal-title":"Br Dent J"},{"issue":"2","key":"2048_CR69","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.tripleo.2007.02.004","volume":"104","author":"SK Ihde","year":"2007","unstructured":"Ihde SK, Konstantinovic VS. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(2):e1-11. https:\/\/doi.org\/10.1016\/j.tripleo.2007.02.004. (Epub 2007\/06\/15. PubMed PMID: 17560141).","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2048_CR70","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1600-0404.2011.01544.x","volume":"191","author":"M Linde","year":"2011","unstructured":"Linde M, Hagen K, Stovner LJ. Botulinum toxin treatment of secondary headaches and cranial neuralgias: a review of evidence. Acta Neurol Scand Suppl. 2011;191:50\u20135. https:\/\/doi.org\/10.1111\/j.1600-0404.2011.01544.x. (Epub 2011\/07\/08. PubMed PMID: 21711257).","journal-title":"Acta Neurol Scand Suppl"},{"key":"2048_CR71","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1590\/S2176-94512012000600029","volume":"17","author":"E Machado","year":"2012","unstructured":"Machado E, Santos LZd, Cust\u00f3dio LG, Cunali PA. Botulinum toxin for treating muscular temporomandibular disorders: a systematic review. Dental Press J Orthodont. 2012;17:167\u201371.","journal-title":"Dental Press J Orthodont"},{"issue":"3","key":"2048_CR72","first-page":"157","volume":"18","author":"R Ataran","year":"2017","unstructured":"Ataran R, Bahramian A, Jamali Z, Pishahang V, Sadeghi Barzegani H, Sarbakhsh P, et al. The role of botulinum toxin A in treatment of temporomandibular joint disorders: a review. J Dent (Shiraz). 2017;18(3):157\u201364 (Epub 2017\/10\/17. PubMed PMID: 29034269; PubMed Central PMCID: PMCPMC5634354).","journal-title":"J Dent (Shiraz)."},{"key":"2048_CR73","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076227","volume":"383","author":"JW Busse","year":"2023","unstructured":"Busse JW, Casassus R, Carrasco-Labra A, Durham J, Mock D, Zakrzewska JM, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023;383: e076227. https:\/\/doi.org\/10.1136\/bmj-2023-076227.","journal-title":"BMJ"},{"issue":"11","key":"2048_CR74","first-page":"737","volume":"69","author":"KH Zawawi","year":"2003","unstructured":"Zawawi KH, Al-Badawi EA, Lobo SL, Melis M, Mehta NR. An index for the measurement of normal maximum mouth opening. J Can Dent Assoc. 2003;69(11):737\u201341 (Epub 2003\/12\/05 PubMed PMID: 14653940).","journal-title":"J Can Dent Assoc"},{"key":"2048_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00016355209058013","volume":"10","author":"U Posselt","year":"1952","unstructured":"Posselt U. Studies in mobility of the human mandible. Acta Odontol Scand. 1952;10:1\u2013160.","journal-title":"Acta Odontol Scand"},{"issue":"4","key":"2048_CR76","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/0022-3913(60)90257-2","volume":"10","author":"J Travell","year":"1960","unstructured":"Travell J. Temporomandibular joint pain referred from muscles of the head and neck. J Prosthet Dent. 1960;10(4):745\u201363.","journal-title":"J Prosthet Dent"},{"issue":"2","key":"2048_CR77","first-page":"81","volume":"67","author":"G Agerberg","year":"1974","unstructured":"Agerberg G. Maximal mandibular movements in young men and women. Sven Tandlak Tidskr. 1974;67(2):81\u2013100 (Epub 1974\/03\/01 PubMed PMID: 4524736).","journal-title":"Sven Tandlak Tidskr"},{"issue":"3","key":"2048_CR78","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0301-0503(78)80085-X","volume":"6","author":"K Landtwing","year":"1978","unstructured":"Landtwing K. Evaluation of the normal range of vertical mandibular opening in children and adolescents with special reference to age and stature. J Maxillofac Surg. 1978;6(3):157\u201362 (Epub 1978\/08\/01 PubMed PMID: 279633).","journal-title":"J Maxillofac Surg"},{"issue":"5","key":"2048_CR79","first-page":"338","volume":"59","author":"AP Vanderas","year":"1992","unstructured":"Vanderas AP. Mandibular movements and their relationship to age and body height in children with or without clinical signs of craniomandibular dysfunction: part IV. A comparative study. ASDC J Dent Child. 1992;59(5):338\u201341 (Epub 1992\/09\/01 PubMed PMID: 1401404).","journal-title":"ASDC J Dent Child"},{"issue":"3","key":"2048_CR80","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/00016357409002543","volume":"32","author":"G Agerberg","year":"1974","unstructured":"Agerberg G. Maximal mandibular movements in children. Acta Odontol Scand. 1974;32(3):147\u201359 (Epub 1974\/01\/01 PubMed PMID: 4531163).","journal-title":"Acta Odontol Scand"},{"issue":"1","key":"2048_CR81","doi-asserted-by":"publisher","first-page":"59","DOI":"10.11607\/ofph.3060","volume":"36","author":"B H\u00e4ggman-Henrikson","year":"2022","unstructured":"H\u00e4ggman-Henrikson B, Jawad N, Acu\u00f1a XM, Visscher CM, Schiffman E, List T. Fear of movement and catastrophizing in participants with temporomandibular disorders. J Oral Facial Pain Headache. 2022;36(1):59\u201366. https:\/\/doi.org\/10.11607\/ofph.3060. (Epub 2022\/03\/18. PubMed PMID: 35298576; PubMed Central PMCID: PMCPMC10586572 authorship and\/or publication of this article).","journal-title":"J Oral Facial Pain Headache"},{"issue":"3","key":"2048_CR82","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.pain.2010.06.002","volume":"150","author":"CM Visscher","year":"2010","unstructured":"Visscher CM, Ohrbach R, van Wijk AJ, Wilkosz M, Naeije M. The Tampa Scale for Kinesiophobia for Temporomandibular Disorders (TSK-TMD). Pain. 2010;150(3):492\u2013500. https:\/\/doi.org\/10.1016\/j.pain.2010.06.002. (Epub 2010\/07\/06. PubMed PMID: 20598804).","journal-title":"Pain"},{"issue":"2","key":"2048_CR83","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.prs.0000239453.67423.99","volume":"119","author":"J-H Kim","year":"2007","unstructured":"Kim J-H, Shin JH, Kim ST, Kim C-Y. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle. Plast Reconstr Surg. 2007;119(2):711\u20137.","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"2048_CR84","first-page":"484","volume":"29","author":"HJ Kim","year":"2003","unstructured":"Kim HJ, Yum KW, Lee SS, Heo MS, Seo K. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Dermatol Surg. 2003;29(5):484\u20139.","journal-title":"Dermatol Surg"},{"issue":"5","key":"2048_CR85","first-page":"477","volume":"29","author":"MY Park","year":"2003","unstructured":"Park MY, Ahn KY, Jung DS. Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg. 2003;29(5):477\u201383.","journal-title":"Dermatol Surg"},{"issue":"3","key":"2048_CR86","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1054\/bjps.2000.3526","volume":"54","author":"EW To","year":"2001","unstructured":"To EW, Ho W, Wong W, Pang PC, Ahuja AT, Hui AC, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg. 2001;54(3):197\u2013200.","journal-title":"Br J Plast Surg"},{"issue":"3","key":"2048_CR87","doi-asserted-by":"publisher","first-page":"390e","DOI":"10.1097\/PRS.0000000000005944","volume":"144","author":"D Shome","year":"2019","unstructured":"Shome D, Khare S, Kapoor R. Efficacy of botulinum toxin in treating Asian Indian patients with masseter hypertrophy: a 4-year follow-up study. Plast Reconstr Surg. 2019;144(3):390e-e396.","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"2048_CR88","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/ar.24756","volume":"305","author":"MC Baldwin","year":"2022","unstructured":"Baldwin MC, Liu ZJ, Rafferty KL, Keith A, Tamasas B, Kaiyala K, et al. Botulinum toxin in the masseter muscle: Lingering effects of denervation. Anat Rec. 2022;305(5):1215\u201330.","journal-title":"Anat Rec"},{"issue":"9","key":"2048_CR89","doi-asserted-by":"publisher","first-page":"Cd007510","DOI":"10.1002\/14651858.CD007510.pub3","volume":"2013","author":"Z Fedorowicz","year":"2013","unstructured":"Fedorowicz Z, van Zuuren EJ, Schoones J. Botulinum toxin for masseter hypertrophy. Cochrane Database Syst Rev. 2013;2013(9):Cd007510. https:\/\/doi.org\/10.1002\/14651858.CD007510.pub3. (Epub 2013\/09\/11. PubMed PMID: 24018587; PubMed Central PMCID: PMCPMC7207780 not have any associations with any parties who may have vested interests in the results of this review).","journal-title":"Cochrane Database Syst Rev"},{"key":"2048_CR90","volume-title":"Pathology of Skeletal Muscle","author":"S Carpenter","year":"2001","unstructured":"Carpenter S, Karpati G. Pathology of Skeletal Muscle. New York: Oxford University Press; 2001."},{"issue":"1","key":"2048_CR91","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1113\/expphysiol.1968.sp001948","volume":"53","author":"L Duchen","year":"1968","unstructured":"Duchen L, Strich SJ. The effects of botulinum toxin on the pattern of innervation of skeletal muscle in the mouse. Q J Exp Physiol Cognate Med Sci Transl Integr. 1968;53(1):84\u20139.","journal-title":"Q J Exp Physiol Cognate Med Sci Transl Integr"},{"issue":"3","key":"2048_CR92","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/01.PRS.0000153236.79775.A0","volume":"115","author":"N-H Kim","year":"2005","unstructured":"Kim N-H, Chung J-H, Park R-H, Park J-B. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg. 2005;115(3):919\u201330.","journal-title":"Plast Reconstr Surg"},{"key":"2048_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14110741","author":"CG De la Torre","year":"2022","unstructured":"De la Torre CG, Camara-Souza MB, Poluha RL, de Figueredo OMC, Nobre BBS, Ernberg M, et al. Long-term effects of a single application of botulinum toxin type A in temporomandibular myofascial pain patients: a controlled clinical trial. Toxins (Basel). 2022. https:\/\/doi.org\/10.3390\/toxins14110741. (Epub 2022\/11\/11. PubMed PMID: 36355991; PubMed Central PMCID: PMCPMC9721314).","journal-title":"Toxins (Basel)."},{"issue":"1","key":"2048_CR94","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/toxins13010006","volume":"13","author":"J-F Montes-Carmona","year":"2021","unstructured":"Montes-Carmona J-F, Gonzalez-Perez L-M, Infante-Cossio P. Treatment of localized and referred masticatory myofascial pain with botulinum toxin injection. Toxins. 2021;13(1):6. https:\/\/doi.org\/10.3390\/toxins13010006.","journal-title":"Toxins"},{"issue":"2","key":"2048_CR95","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3344\/kjp.2022.35.2.127","volume":"35","author":"GJ Choi","year":"2022","unstructured":"Choi GJ, Kang H. The umbrella review: a useful strategy in the rain of evidence. Korean J Pain. 2022;35(2):127\u20138. https:\/\/doi.org\/10.3344\/kjp.2022.35.2.127. (Epub 2022\/04\/01. PubMed PMID: 35354675; PubMed Central PMCID: PMCPMC8977198 was reported).","journal-title":"Korean J Pain."}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-024-02048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-024-02048-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-024-02048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T10:24:51Z","timestamp":1722335091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-024-02048-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":95,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2048"],"URL":"https:\/\/doi.org\/10.1007\/s40265-024-02048-x","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,20]]},"assertion":[{"value":"12 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Karolinska Institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"G. De la Torre Canales, M.B. C\u00e2mara-Souza,, M. Ernberg, E.A. Al-Moraissi, A. Grigoriadis, R.L. Poluha, M. Christidis, H. Jasim, A. L\u00f6vgren, and N. Christidis all declare that they have no conflicts of interest that might be relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent (participation and publication)"}},{"value":"The datasets generated and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Nikolaos Christidis and Giancarlo De la Torre Canales conceived the main idea for the article. However, all authors contributed to the study conception and design. Hajer Jasim and Anna L\u00f6vgren performed the literature search with help from the university library at Karolinska Institutet. Selection of papers was performed by Hajer Jasim and Anna L\u00f6vgren. The protocols for data extraction and the risk of bias were developed by Giancarlo De la Torre Canales, Nikolaos Christidis, Anastasios Grigoriadis, and Essam Ahmed Al-Moraissi. Data extraction was done by Mariana Barbosa C\u00e2mara-Souza and Malin Ernberg. Analysis of risk of bias was performed by Rodrigo Lorenzi Poluha and Maria Christidis. Maria Christidis is a senior lecturer and responsible for the course \u201cScientific theory and methods,\u201d and teaches specifically about different methods for risk of bias and evaluation of certainty of evidence. The synthesis of the results was performed by Giancarlo De la Torre Canales and Nikolaos Christidis and double-checked by Anastasios Grigoriadis and Essam Ahmed Al-Moraissi. Further, both Nikolaos Christidis and Giancarlo De la Torre Canales double checked all parts of the data extraction, assessment of risk of bias, and certainty of evidence. Giancarlo De la Torre Canales and Nikolaos Christidis drafted the first manuscript, which was critically revised by all authors who commented on previous versions of the manuscript. All authors read and approved the final version manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}